Axitinib: Treatment of advanced renal cell carcinoma
The medicine Axitinib is used for treating patients with advanced renal cell carcinoma after failure of one prior systemic therapy. Axitinib is an inhibitor of tyrosine kinases, including vascular endothelial growth factor receptors (VEGFR)-1, VEGFR-2, and VEGFR-3 at therapeutic plasma concentrations. These receptors are implicated in pathologic angiogenesis, tumor growth, and cancer progression. The active ingredient in the medicine is Axitinib, and the inactive ingredients are microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium stearate, and Opadry? II red 32K15441. This medicine comes in 1 mg and 5mg tablets for oral administration. Axitinib 5 mg tablet is readily available in India, and one can buy this medicine from various generic medicine suppliers. To know more, dial 18008891064.
Related Bookmarks
- DELICIOUS GOUT-FRIENDLY RECIPES YOU DON�T WANT TO MISS
- AAHWAHAN FOUNDATION'S COVID INITIATIVE PROVIDES FREE CONSULTATION AND MEDICINE TO THE UNDERPRIVILEGE
- Seguro de vida con beneficios de vida en Broward | Segurosenvida.com
- Best Medicine for Jaryan Treatment
- The RNA targeting small molecule therapies market is projected to be worth around USD 8.3 billion in
- Advance Level Services by Panchmukhi Road Ambulance Service in Thoubal
- Biopharmaceutical Excipient Manufacturing Market by Type of Biologics (Antibodies, Vaccines, Cell Th
- High Blood Pressure � Causes, Symptoms, and Prevention
- HCG Diet Treatment Center in Weston
- Is the use of a Body Vibration Machine in Pediatric Rehabilitation Helpful?
Recent Profiles
Fb88 Win
Kèo Nhà Cái M88
Garden Set With Cushions
Elephgame
Fu99 Com
Smdb Talent Solutions
Go88
Tsw Financial Llc
Amaia Freyja
Cabhire